Global Longlife — 360° view

Global Longlife, a company in the Hospital industry, reported revenue of ₹0.58 crore and net profit of ₹1.24 crore for the September 2024 quarter.

Global Longlife (BSE: GLHRL) closed at ₹15.68 on 20 Nov 2026, down 22.3% over the past year. Its market capitalisation is ₹16 crore.

Share price
₹15.68 (20 Nov 2026)
Market cap
₹16 Cr (20 Nov 2026)
Revenue
₹1 Cr (September 2024 quarter)
Net profit
₹1 Cr (September 2024 quarter)
ROCE
-3.92% (FY26)
ROE
-6.81% (FY26)
Book value
₹22.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹25.60 / ₹9.00 (20 Nov 2026)
1-year return
-22.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
BSE: GLHRL

Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.